GLP Watchdog

Aspire Health vs RxION Health

Neither Aspire Health nor RxION Health has an FDA warning letter on record. No price lines up like for like. They share compounded semaglutide injection, but Aspire Health's $103 covers the medication only, with a separate care fee on top.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Aspire Health / RxION Health

Aspire Health logo

Aspire Health

9.0/10

RxION Health logo

RxION Health

8.3/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$103/moCompounded semaglutide injection, medication only, care fee extra
$149/moCompounded semaglutide injection
States
29 states
47 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Aspire HealthFull review
Visit RxION HealthFull review

Neither Aspire Health nor RxION Health pays us. Links to them earn nothing. Scores: Aspire Health 9.0, RxION Health 8.3. How we are paid

What the record shows

  1. 01

    Neither Aspire Health nor RxION Health has an FDA warning letter on record.

  2. 02

    Aspire Health names three pharmacies, all 503A. RxION Health names no compounding pharmacy in our record.

  3. 03

    No price lines up like for like. They share compounded semaglutide injection, but Aspire Health's $103 covers the medication only, with a separate care fee on top.

  4. 04

    Aspire Health covers one state RxION Health does not and RxION Health covers 19 states Aspire Health does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Aspire Health

RxION Health

Compounded semaglutide injection

$103/mo

medication only, care fee extra; not compared

$149/mo

$1,788 a year

Compounded tirzepatide injection

$149/mo

medication only, care fee extra; not compared

$199/mo

$2,388 a year

Brand-name semaglutide pen

$199/mo

medication only, care fee extra; not compared

$1,499/mo

$17,988 a year

Brand-name tirzepatide pen

$299/mo

medication only, care fee extra; not compared

$1,259/mo

$15,108 a year

Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Billed separately
Labs
Not stated
Cancel any time
Yes, stated
Yes, stated
Minimum term
$49 Weight Management fee every 28 days, required while on medication
None on the monthly plan; prepaid plans cover 3 or 6 months
Refunds
No refunds for partial billing periods; compounded charges are non‑refundable once sent to the pharmacy
Medication portion refunded if not approved; the $75 consult fee and issued prescriptions are not refundable
Early-exit fee
None stated
None stated

Read off each seller’s own pages. Aspire Health: October 25, 2026. RxION Health: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Aspire Health

9.0/10
  • Names its compounding pharmacy
  • Price leaves out labs
  • Lowest price covers the medication only, with a separate care fee on top
Visit Aspire Health

The case for RxION Health

8.3/10
  • Lists 47 states against 29
  • Names no compounding pharmacy
Visit RxION Health

Scores

Aspire Health 9.0 · RxION Health 8.3 out of 10. Six weighted parts.

Value25%

9.8A
vs
B
7.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

10.0A
vs
B
7.5

Accessibility10%

6.6A
vs
B
9.5

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Aspire Health vs RxION Health: questions

Neither Aspire Health nor RxION Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Aspire Health names three pharmacies, all 503A. RxION Health names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
No price lines up like for like. They share compounded semaglutide injection, but Aspire Health's $103 covers the medication only, with a separate care fee on top. We only set two prices against each other when they are for the same product and both are standing month-to-month or 4-week rates.
Aspire Health states you can cancel at any time; refunds: no refunds for partial billing periods; compounded charges are non‑refundable once sent to the pharmacy. RxION Health states you can cancel at any time; refunds: medication portion refunded if not approved; the $75 consult fee and issued prescriptions are not refundable.
Neither Aspire Health nor RxION Health pays us. Links to them earn nothing. Scores: Aspire Health 9.0, RxION Health 8.3.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks